Stock Trading Canary← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Christine Elizabeth Rankin
Styrelseledamot
Profile key: se|christine elizabeth rankin
Purchase history
- Companies traded
- 3
- Purchases · 12M
- 3
- Purchases · 24M
- 6
- Average purchase
- SEK 56,087
- Gross purchase value
- SEK 336,522
- Last purchase
- 2026-08-26
- Completed 20D events
- 6.0
- Outcome status
- PASS
Latest company: BONESUPPORT HOLDING AB
Companies: BONESUPPORT HOLDING AB | Oncopeptides AB | Orexo AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 6Developing | 100.0% (6/6) | 83.3% (5/6) | +2.8% | +2.7% | -4.0% |
| 20D | 6Developing | 100.0% (6/6) | 33.3% (2/6) | -3.8% | +2.1% | -11.4% |
| 60D | 5Developing | 100.0% (5/5) | 80.0% (4/5) | +4.3% | +10.8% | -15.3% |
| 120D | 5Developing | 100.0% (5/5) | 60.0% (3/5) | +0.7% | -4.8% | -83.9% |
Research patterns
- First purchase in 12M
- 2/4
- Large purchase ≥ €100k
- 0/6
- Cluster buying · 15D
- 2/6
- Buying the dip · ≥20% below prior 52W high
- 5/6
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.